As of 1:51pm ET
| -0.1299 / -1.88%|
The 3 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 12.00. The median estimate represents a +120.91% increase from the last price of 6.79.
The current consensus among 3 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.